GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ZYUS Life Sciences Corp (TSXV:ZYUS) » Definitions » PS Ratio

ZYUS Life Sciences (TSXV:ZYUS) PS Ratio : 204.00 (As of May. 26, 2024)


View and export this data going back to 2023. Start your Free Trial

What is ZYUS Life Sciences PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, ZYUS Life Sciences's share price is C$1.02. ZYUS Life Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.01. Hence, ZYUS Life Sciences's PS Ratio for today is 204.00.

Good Sign:

ZYUS Life Sciences Corp stock PS Ratio (=170) is close to 1-year low of 160

The historical rank and industry rank for ZYUS Life Sciences's PS Ratio or its related term are showing as below:

TSXV:ZYUS' s PS Ratio Range Over the Past 10 Years
Min: 160   Med: 200   Max: 432.5
Current: 204

During the past 3 years, ZYUS Life Sciences's highest PS Ratio was 432.50. The lowest was 160.00. And the median was 200.00.

TSXV:ZYUS's PS Ratio is ranked worse than
98.8% of 999 companies
in the Drug Manufacturers industry
Industry Median: 2.16 vs TSXV:ZYUS: 204.00

ZYUS Life Sciences's Revenue per Sharefor the three months ended in Dec. 2023 was C$0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.01.

During the past 12 months, the average Revenue per Share Growth Rate of ZYUS Life Sciences was 50.00% per year.

Back to Basics: PS Ratio


ZYUS Life Sciences PS Ratio Historical Data

The historical data trend for ZYUS Life Sciences's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ZYUS Life Sciences PS Ratio Chart

ZYUS Life Sciences Annual Data
Trend Dec21 Dec22 Dec23
PS Ratio
- - 150.00

ZYUS Life Sciences Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PS Ratio Get a 7-Day Free Trial Premium Member Only - - 286.00 200.00 150.00

Competitive Comparison of ZYUS Life Sciences's PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, ZYUS Life Sciences's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ZYUS Life Sciences's PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ZYUS Life Sciences's PS Ratio distribution charts can be found below:

* The bar in red indicates where ZYUS Life Sciences's PS Ratio falls into.



ZYUS Life Sciences PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

ZYUS Life Sciences's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=1.02/0.005
=204.00

ZYUS Life Sciences's Share Price of today is C$1.02.
ZYUS Life Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


ZYUS Life Sciences  (TSXV:ZYUS) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


ZYUS Life Sciences PS Ratio Related Terms

Thank you for viewing the detailed overview of ZYUS Life Sciences's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


ZYUS Life Sciences (TSXV:ZYUS) Business Description

Traded in Other Exchanges
Address
407 Downey Road, Unit 204, Saskatoon, SK, CAN, S7N 4L8
ZYUS Life Sciences Corp is a next-generation life sciences company engaged in scientific research and development in phyto-therapeutics, including cannabinoid and protein-based formulations. It is committed to delivering high-quality standardized therapeutic formulations that comply with Good Manufacturing Practices (GMP) to provide targeted relief for patients in Canada and globally.
Executives
John Michael Hyshka Senior Officer

ZYUS Life Sciences (TSXV:ZYUS) Headlines

No Headlines